Stock 4565 NXERA PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Nxera Pharma Co., Ltd.

Equities

4565

JP3431300007

Delayed Japan Exchange
Other stock markets
 08:00:00 15/05/2024 am IST 		5-day change 1st Jan Change
1,578 JPY +1.02% Intraday chart for Nxera Pharma Co., Ltd. +2.07% +11.05%
18/04 Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May MT
17/04 Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nxera Pharma Appoints Patrick Branch as Head of Business Development for Japan and APAC
CI
Sosei Shareholders Greenlight Name Change, Top Management Appointments
MT
Sosei Group Changes Names of Company, Subsidiaries
MT
Sosei Group Corporation Appoints Toshihiro Maeda as Chief Operating Officer
CI
Sosei Heptares and Kallyope Nominate First Gpcr Target for Therapeutic Development in Gastrointestinal Diseases
CI
Sosei Group Corporation Announces Executive Appointments
CI
Sosei Group Corporation Approves Management Changes
CI
Sosei Group Corporation Approves Executive Changes
CI
Sosei Group Corporation Appoints Chris Cargill to the New Role of Group Chief Operating Officer
CI
Sosei Group Corporation Appoints Hironoshin Nomura, as Senior Vice President Investor Relations and Corporate Strategy
CI
Sosei Group Corporation Appoints Rolf Soderstrom as New Board Director and Promotes Dr. Malcolm Weir to Executive Vice Chairman
CI
Sosei Heptares Announces Management Changes
CI
Sosei : Heptares announces nomination of a third clinical candidate by Pfizer from multi-target drug discovery collaboration
AQ
Sosei Heptares Announces Nomination of a Third Clinical Candidate by Pfizer from Multi-Target Drug Discovery Collaboration
CI
Sosei Group Corporation Announces the Appointment of Mr. Noriaki Nagai as External Director
CI
Sosei Group Corporation Announces Management Changes
CI
Sosei Group Corporation Appoints Chris Cargill as Executive Vice President and Chief Financial Officer
CI
Sosei Group Corporation Announces Executive Changes
CI
Sosei : Notice of Withdrawal of New External Director Nomination
PU
Sosei Group Corporation to Withdraw Nomination of Michael Hayden as A New External Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4565 Stock
  4. News Nxera Pharma Co., Ltd.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW